Merck’s Gardasil Adds Serotypes; Boosting Vaccinations Seems Bigger Challenge
Promotion strategy likely to remain same after nine-valent HPV vaccine wins FDA approval; Merck may need help from the CDC to overcome cultural barriers to adoption.
You may also be interested in...
Complete response letter for Acacia’s Barhemsys is only rain on Oct. 5 approval parade.
Sentinel will consider data from 3m doses of Merck's nine-valent HPV vaccine.
Study finds no increased risk of venous thromboembolism in more than 650,000 females vaccinated with the HPV vaccine; no labeling changes requested by FDA.